Stenting Versus Balloon Angioplasty in Idiopathic Intracranial Hypertension Patients with Venous Sinus Stenosis

doi:10.3969/j.issn.1673-5765.2019.10.002

Abstract

Abstract:

Objective To compare the clinical outcome of patients with idiopathic intracranial hypertension (IIH) and venous sinus stenosis (VSS) treated by stenting and balloon angioplasty. Methods The baseline characteristics, operative procedure, perioperative management and clinical outcome of consecutive IIH and VSS patients who underwent stenting and balloon angioplasty in Beijing Tian Tan Hospital, Capital Medical University were prospectively recorded from January 2012 to December 2015. The treatment strategy was decided by consultation between interventional neurologists and patients’ authorized representatives. According to the different treatment options, the eligible patients were divided into stent group and balloon group. The clinical outcome was defined as symptoms unchanged, symptoms improve or symptoms disappear. The proportion of patients with symptoms disappearing at post-procedure 3, 6 and 12 months between both groups was compared. Results A total of 45 patients were finally enrolled in this study, with 26 cases were in the stent group and 19 cases in the balloon group. The baseline characteristics of both groups had no statistical difference. The intracranial venous sinus trans-stenosis pressure difference in stenting group was lower than that in balloon group (0 vs 7 mm Hg, P <0.001). The patients treated with stenting exhibited a higher proportion of asymptomatic conditions at 3 months (57.7% vs 0, P <0.001), 6 months (88.5% vs 5.9%, P <0.001) and 12 months (88.5% vs 23.5%, P =0.001) than those treated with balloon angioplasty. Conclusions Compared with balloon angioplasty, stenting showed a better efficacy for IIH and VSS patients. Future randomized controlled multicenter trials are required to confirm our findings.

Key words: Idiopathic intracranial hypertension; Venous sinus stenosis; Stenting; Balloon angioplasty

摘要：

目的本研究旨在比较支架置入与球囊扩张治疗特发性颅内高压（idiopathic intracranial hypertension， IIH）伴静脉窦狭窄的疗效差异。方法对2012年1月-2015年12月在首都医科大学附属北京天坛医院接受介入治疗（支架置入或球囊扩张）的IIH伴静脉窦狭窄患者的基线特征、手术过程、围手术期管理和临床结局进行了前瞻性连续性登记。介入治疗方案由神经介入医师和患者协商决定。临床结局改善程度分为3级：症状消失、症状改善、症状无变化或加重。通过比较支架组和球囊扩张组术后3个月、6个月、12个月症状消失的比例，探讨两种治疗方法的疗效差异。结果本研究共纳入45例患者，其中支架组26例，球囊扩张组19例。两组患者的基线人口学特征差异无统计学意义。支架组术后颅内静脉窦狭窄两端的压力差显著低于球囊扩张组（中位数：0 vs 7 mm Hg，P <0.001）。与球囊扩张相比，接受支架置入治疗的患者术后3个月（57.7% vs 0， P <0.001）、6个月（88.5% vs 5.9%，P <0.001）和12个月（88.5% vs 23.5%，P =0.001）症状消失的比例更高，提示临床预后更好。结论支架置入治疗IIH伴静脉窦狭窄的效果优于球囊扩张，但该结论还需要未来开展多中心随机对照试验来进一步证实。

关键词: 特发性颅内高压; 静脉窦狭窄; 支架置入; 球囊扩张

TONG Xu, WANG Su-Jie, WANG Yi-Long, MIAO Zhong-Rong, MO Da-Peng. Stenting Versus Balloon Angioplasty in Idiopathic Intracranial Hypertension Patients with Venous Sinus Stenosis[J]. Chinese Journal of Stroke, 2019, 14(10): 968-974.

佟旭, 王素洁, 王伊龙, 缪中荣, 莫大鹏. 支架置入与球囊扩张治疗特发性颅内高压伴静脉窦狭窄的疗效比较[J]. 中国卒中杂志, 2019, 14(10): 968-974.

Add to citation manager EndNote|Ris|BibTeX

URL: https://www.chinastroke.org.cn/EN/10.3969/j.issn.1673-5765.2019.10.002

https://www.chinastroke.org.cn/EN/Y2019/V14/I10/968

References

[1] KARAHALIOS D G，REKATE H L，KHAYATA

M H，et al. Elevated intracranial venous pressure as

a universal mechanism in pseudotumor cerebri of

varying etiologies[J]. Neurology，1996，46（1）：198-

202.

[2] FRIEDMAN D I，JACOBSON D M. Diagnostic

criteria for idiopathic intracranial hypertension[J].

Neurology，2002，59（10）：1492-1495.

[3] BALL A K，CLARKE C E. Idiopathic intracranial

hypertension[J]. Lancet Neurol，2006，5（5）：433-

442.

[4] MARKEY K A，MOLLAN S P，JENSEN R H，et al.

Understanding idiopathic intracranial hypertension：

mechanisms，management，and future directions[J].

Lancet Neurol，2016，15（1）：78-91.

[5] FARB R I，VANEK I，SCOTT J N，et al. Idiopathic

intracranial hypertension：the prevalence and

morphology of sinovenous stenosis[J]. Neurology，

2003，60（9）：1418-1424.

[6] HIGGINS J N，GILLARD J H，OWLER B K，et

al. MR venography in idiopathic intracranial

hypertension：unappreciated and misunderstood[J].

J Neurol Neurosurg Psychiatry，2004，75（4）：621-

625.

[7] MOLLAN S P，ALI F，HASSAN-SMITH G，et al.

Evolving evidence in adult idiopathic intracranial

hypertension：pathophysiology and management[J].

J Neurol Neurosurg Psychiatry，2016，87（9）：982-

992.

[8] KING J O，MITCHELL P J，THOMSON K R，et

al. Manometry combined with cervical puncture in

idiopathic intracranial hypertension[J]. Neurology，

2002，58（1）：26-30.

[9] ROHR A，DÖRNER L，STINGELE R，et

al. Reversibility of venous sinus obstruction in

idiopathic intracranial hypertension[J]. AJNR Am J

Neuroradiol，2007，28（4）：656-659.

[10] HIGGINS J N，OWLER B K，COUSINS C，et

al. Venous sinus stenting for refractory benign

intracranial hypertension[J]. Lancet，2002，359

（9302）：228-230.

[11] HIGGINS J N，COUSINS C，OWLER B K，et al.

Idiopathic intracranial hypertension：12 cases treated

by venous sinus stenting[J]. J Neurol Neurosurg

Psychiatry，2003，74（12）：1662-1666.

[12] DONNET A，METELLUS P，LEVRIER O，et al.

Endovascular treatment of idiopathic intracranial

hypertension：clinical and radiologic outcome of 10

consecutive patients[J]. Neurology，2008，70（8）：

641-647.

[13] BUSSIÈRE M，FALERO R，NICOLLE D，et al.

Unilateral transverse sinus stenting of patients with

idiopathic intracranial hypertension[J]. AJNR Am J

Neuroradiol，2010，31（4）：645-650.

[14] AHMED R M，WILKINSON M，PARKER G

D，et al. Transverse sinus stenting for idiopathic

intracranial hypertension：a review of 52 patients

and of model predictions[J]. AJNR Am J Neuroradiol，

2011，32（8）：1408-1414.

[15] KUMPE D A，BENNETT J L，SEINFELD J，et

al. Dural sinus stent placement for idiopathic

intracranial hypertension[J]. J Neurosurg，2012，116

（3）：538-548.

[16] LAZZARO M A，DARKHABANI Z，REMLER B

F，et al. Venous sinus pulsatility and the potential

role of dural incompetence in idiopathic intracranial

hypertension[J]. Neurosurgery，2012，71（4）：877-

883.

[17] FIELDS J D，JAVEDANI P P，FALARDEAU J，et al.

Dural venous sinus angioplasty and stenting for the

treatment of idiopathic intracranial hypertension[J].

J Neurointerv Surg，2013，5（1）：62-68.

[18] DUCRUET A F，CROWLEY R W，MCDOUGALL

C G，et al. Long-term patency of venous sinus

stents for idiopathic intracranial hypertension[J]. J

Neurointerv Surg，2014，6（3）：238-242.[19] TELEB M S，CZIEP M E，ISSA M，et al. Stenting

and angioplasty for idiopathic intracranial

hypertension：a case series with clinical，

angiographic，ophthalmological，complication，and

pressure reporting[J]. J Neuroimaging，2015，25（1）：

72-80.

[20] DINKIN M J，PATSALIDES A. Venous sinus

stenting in idiopathic intracranial hypertension：

results of a prospective trial[J]. J Neuroophthalmol，

2017，37（2）：113-121.

[21] LENCK S，VALLÉE F，LABEYRIE M A，et al.

Stenting of the lateral sinus in idiopathic intracranial

hypertension according to the type of stenosis[J].

Neurosurgery，2017，80（3）：393-400.

[22] LEVITT M R，ALBUQUERQUE F C，DUCRUET

A F，et al. Venous sinus stenting for idiopathic

intracranial hypertension is not associated with

cortical venous occlusion[J]. J Neurointerv Surg，

2016，8（6）：594-595.

[23] FRIEDMAN D I，LIU G T，DIGRE K B. Revised

diagnostic criteria for the pseudotumor cerebri

syndrome in adults and children[J]. Neurology，2013，

81（13）：1159-1165.

[24] SINCLAIR A J，BURDON M A，NIGHTINGALE

P G，et al. Low energy diet and intracranial pressure

in women with idiopathic intracranial hypertension：

prospective cohort study[J/OL]. BMJ，2010，341：

c2701. https：//doi.org/10.1136/bmj.c2701.

[25] NORDIC Idiopathic Intracranial Hypertension

Study Group Writing Committee，WALL M，

MCDERMOTT M P，et al. Effect of acetazolamide

on visual function in patients with idiopathic

intracranial hypertension and mild visual loss：the

idiopathic intracranial hypertension treatment

trial[J]. JAMA，2014，311（16）：1641-1651.

[26] KOLLAR C，PARKER G，JOHNSTON I.

Endovascular treatment of cranial venous sinus

obstruction resulting in pseudotumor syndrome.

Report of three cases[J]. J Neurosurg，2001，94（4）：

646-651.

[27] YANG M S，CHEN C C，HUNG H C，et al.

Angioplasty as the first-line therapeutic option for

venous hypertension with outlet obstruction of dural

sinus[J]. Neuroradiol J，2008，21（1）：121-127.

[28] TELEB M S，CZIEP M E，LAZZARO M A，et al.

Idiopathic intracranial hypertension. A systematic

analysis of transverse sinus stenting[J]. Interv Neurol，

2013，2（3）：132-143.

[29] KING J O，MITCHELL P J，THOMSON K R，et al.

Cerebral venography and manometry in idiopathic

intracranial hypertension[J]. Neurology，1995，45

（12）：2224-2228.